Solution structure of rat apo-S100B(beta beta) as determined by NMR spectroscopy
about
S100A6 and S100A11 are specific targets of the calcium- and zinc-binding S100B protein in vivoThe structure of Ca2+-loaded S100A2 at 1.3-Å resolutionStructural and functional insights into RAGE activation by multimeric S100BThe use of dipolar couplings for determining the solution structure of rat apo-S100B(ββ)The Effects of CapZ Peptide (TRTK-12) Binding to S100B–Ca2+ as Examined by NMR and X-ray CrystallographyA 1.3-Å Structure of Zinc-bound N-terminal Domain of Calmodulin Elucidates Potential Early Ion-binding StepSolution structure of the novel dispersin protein of enteroaggregative Escherichia coliStructure of Ca 2+ -Bound S100A4 and Its Interaction with Peptides Derived from Nonmuscle Myosin-IIA †Small Molecules Bound to Unique Sites in the Target Protein Binding Cleft of Calcium-Bound S100B As Characterized by Nuclear Magnetic Resonance and X-ray CrystallographyIn vitro screening and structural characterization of inhibitors of the S100B-p53 interactionStructure of the Small Dictyostelium discoideum Myosin Light Chain MlcB Provides Insights into MyoB IQ Motif RecognitionHeterocomplex formation between metastasis-related protein S100A4 (Mts1) and S100A1 as revealed by the yeast two-hybrid systemThe calcium-modulated proteins, S100A1 and S100B, as potential regulators of the dynamics of type III intermediate filamentsA model for target protein binding to calcium-activated S100 dimersSolvation energetics and conformational change in EF-hand proteinsA calbindin D9k mutant containing a novel structural extension: 1H nuclear magnetic resonance studies.The heterodimeric complex of MRP-8 (S100A8) and MRP-14 (S100A9). Antibody recognition, epitope definition and the implications for structure.A biosensor of S100A4 metastasis factor activation: inhibitor screening and cellular activation dynamics.Diversity of conformational states and changes within the EF-hand protein superfamily.Mapping the zinc ligands of S100A2 by site-directed mutagenesis.Covalent small molecule inhibitors of Ca(2+)-bound S100B.Molecular determinants of S100B oligomer formationSmall Molecule Inhibitors of Ca(2+)-S100B Reveal Two Protein Conformations.Oligomerization state of S100B at nanomolar concentration determined by large-zone analytical gel filtration chromatographyS100B(betabeta) inhibits the protein kinase C-dependent phosphorylation of a peptide derived from p53 in a Ca2+-dependent manner.Structural changes in the C-terminus of Ca2+-bound rat S100B (beta beta) upon binding to a peptide derived from the C-terminal regulatory domain of p53.Target binding to S100B reduces dynamic properties and increases Ca(2+)-binding affinity for wild type and EF-hand mutant proteins.Novel protein-inhibitor interactions in site 3 of Ca(2+)-bound S100B as discovered by X-ray crystallography.Total chemical synthesis and chemotactic activity of human S100A12 (EN-RAGE).Structural basis for the negative allostery between Ca(2+)- and Mg(2+)-binding in the intracellular Ca(2+)-receptor calbindin D9kThe Calcium-Dependent Interaction of S100B with Its Protein Targets.Identification of the binding site on S100B protein for the actin capping protein CapZ.Cloning, overexpression, purification, and spectroscopic characterization of human S100P.Evidence for the involvement of the unique C-tail of S100A9 in the binding of arachidonic acid to the heterocomplex S100A8/A9.The C terminus (amino acids 75-94) and the linker region (amino acids 42-54) of the Ca2+-binding protein S100A1 differentially enhance sarcoplasmic Ca2+ release in murine skinned skeletal muscle fibers.Binding of Ca2+ and Zn2+ to human nuclear S100A2 and mutant proteins.NMR investigation and secondary structure of domains I and II of rat brain calbindin D28k (1-93).Interaction of isoforms of S100 protein with smooth muscle caldesmon.The structure of the human centrin 2-xeroderma pigmentosum group C protein complex.
P2860
Q22254674-93D172AC-2AF8-4566-8E26-6D1C8E15DC80Q24306778-CF7AE9F6-F4F1-4ECE-AD7C-5CD2BCA530ABQ24322846-6A079958-5541-4EEF-AF2D-35A59216D11CQ27618002-F4F7A9BA-2384-4AAF-A9D3-2F8A56A4A4B5Q27646625-7624B729-D16A-45F6-9CF0-F16D8E7CED91Q27648809-53C2BCBD-82A6-4FDB-B9D3-92BB032A14F2Q27648971-91F5667D-134F-494D-A7C4-ADDFE7342513Q27650317-925999B1-3A90-4315-B4EA-8FF5E5324BD5Q27655607-39440D82-6D55-4E31-B352-445F0E821827Q27666186-D64DFF53-382C-47C1-AD83-7EA76894EBDEQ27683620-33A226B4-88DD-4F5E-9F37-CA8AB49D0E64Q28139278-A5A50CD3-799B-4841-A150-844B037FDC16Q28145516-ED48749F-664A-452A-BCF3-383B512FC935Q28262190-A2E0DF3D-0C1A-443D-B795-4321DD2DBEF2Q28361359-F5637896-C645-4882-A693-2B90D0616D91Q30426548-DACD91C3-D82D-4DE1-92DF-91F385A57434Q30978929-2CE8CE6D-6FFB-4BCA-8518-52A10D478D6AQ33312065-AC8FA7DE-F2E5-4039-9DEC-55D52A48AA23Q33790634-179555B6-9368-462F-8B98-6D1B53E1A9AEQ33899997-71DEEB72-EB55-451B-B3C8-9AAFF30B4D02Q34414451-A76AD9CB-F00B-429D-B176-34BF75D75114Q34698701-04A2E6E0-5078-45BD-B391-DDEE9C1704C5Q35884035-7562D864-0AEE-4097-973E-2108C8153F96Q36280521-02D892F1-420B-430F-914A-3D1EBA98EA88Q36280846-02E95797-081F-4774-B29E-89F1908D2321Q36281652-BD6173EF-4FDD-4E78-9FD8-5844BC7257FBQ36291452-9925C2DD-2231-4F71-A696-DF10E8ADC545Q37006985-395DAA76-CB19-4CD3-95B8-7C9A42FE5912Q40829426-A3D11560-A02C-4C57-BC36-DD41486CD8A5Q42253823-3BBEAE4A-4C55-4F30-90FC-D82C8177E295Q42431159-F41B24E9-B6D3-46FC-9BAF-D5803F233601Q42845697-6AC3550E-690A-4C32-BA06-3F9B08C11069Q42846107-182A2114-9A2E-4F6B-82F9-97C91F1597B8Q44293864-137D8299-B29D-4425-BAE1-5EC8E03E40B6Q44422856-F29412A0-506D-48AD-A98A-A8730426CCF8Q47828552-2649916E-5582-4382-92A0-A68B5BDBBF4BQ48159629-BC4F3C5E-BD45-41DD-BBBC-A473C0C8D6F0Q48518541-D99E32D8-ACD7-4277-9381-E6D0EE7EF89FQ53626607-02096740-819C-4C15-8CF4-CD2967248455
P2860
Solution structure of rat apo-S100B(beta beta) as determined by NMR spectroscopy
description
1996 nî lūn-bûn
@nan
1996 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Solution structure of rat apo-S100B(beta beta) as determined by NMR spectroscopy
@ast
Solution structure of rat apo-S100B(beta beta) as determined by NMR spectroscopy
@en
Solution structure of rat apo-S100B(beta beta) as determined by NMR spectroscopy
@nl
type
label
Solution structure of rat apo-S100B(beta beta) as determined by NMR spectroscopy
@ast
Solution structure of rat apo-S100B(beta beta) as determined by NMR spectroscopy
@en
Solution structure of rat apo-S100B(beta beta) as determined by NMR spectroscopy
@nl
prefLabel
Solution structure of rat apo-S100B(beta beta) as determined by NMR spectroscopy
@ast
Solution structure of rat apo-S100B(beta beta) as determined by NMR spectroscopy
@en
Solution structure of rat apo-S100B(beta beta) as determined by NMR spectroscopy
@nl
P2093
P356
P1433
P1476
Solution structure of rat apo-S100B(beta beta) as determined by NMR spectroscopy
@en
P2093
D Baldisseri
F Abildgaard
J C Amburgey
M R Starich
P304
11577-11588
P356
10.1021/BI9612226
P407
P577
1996-09-01T00:00:00Z